AI assistant
CONMED Corp — Director's Dealing 2016
Jun 3, 2016
31971_dirs_2016-06-03_57c4b111-6849-4ef2-9614-c9842d8fab70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-06-01
Reporting Person: CONCANNON BRIAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-01 | Common Stock | M | 3000 | — | Acquired | 9000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-01 | Rsus (restricted Stock Units) | $0 | M | 3000 | Disposed | 2025-06-01 | Common Stock (3000) | Direct |
| 2016-06-01 | Options To Purchase Common Stock | $41.06 | A | 5396 | Acquired | 2026-06-01 | Common Stock (5396) | Direct |
| 2016-06-01 | Rsus (restricted Stock Units) | $0 | A | 2739 | Acquired | 2026-06-01 | Common Stock (2739) | Direct |
Footnotes
F1: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.